← Back to Search

Neurosurgical Procedure

Deep Brain Stimulation for Spasmodic Dysphonia

N/A
Recruiting
Led By S. Elizabeth Zauber, MD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up before surgery, within 24 hours after surgery, 6-9 months after surgery
Awards & highlights

Study Summary

This trial will enroll people with Adductor Laryngeal Dystonia (ADLD) to study the efficacy of Deep Brain Stimulation (DBS) in treating the condition. DBS is a neurosurgical procedure used to treat tremors and dystonia. Before surgery, participants will undergo specialized testing to study the movement of the vocal cords, as well as functional MRI. In the operating room, researchers will examine brain waves to better understand how faulty brain firing patterns lead to dystonia. After surgery, participants will repeat speech testing and vocal cord imaging as well as MRI.

Eligible Conditions
  • Spasmodic Dysphonia
  • Adductor Spastic Dysphonia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~before surgery, within 24 hours after surgery, 6 -9 months after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and before surgery, within 24 hours after surgery, 6 -9 months after surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Acoustic voice recordings
Change in total number of Vocal fold movements
Microelectrode recording
Secondary outcome measures
Change in Neuropsychological testin: Trails B
Change in Neuropsychological testing: Controlled Oral Word Association Animal fluency
Change in Neuropsychological testing: Trails A
+3 more

Side effects data

From 2018 Phase 2 trial • 53 Patients • NCT01221948
23%
Fall
15%
Depression
8%
Hand fracture
8%
Restless legs syndrome
8%
Apathy
5%
Head injury
5%
Dyspepsia
5%
Back pain
5%
Speech disorder
5%
Skeletal injury
5%
Tremor
5%
Gait disturbance
5%
Dystonia
5%
Paraesthesia
5%
Influenza
5%
Urinary tract infection
3%
Pain in extremity
3%
Diabetes mellitus
3%
Intervertebral disc protrusion
3%
Spinal osteoarthritis
3%
Fluid retention
3%
Postoperative wound infection
3%
Osteoarthritis
3%
Macular degeneration
3%
Hypoaesthesia
3%
Ingrowing nail
3%
Respiratory depression
3%
Parkinson's disease
3%
Akinesia
3%
Productive cough
3%
Device migration
3%
Syncope
3%
Diplopia
3%
Skin laceration
3%
Joint sprain
3%
Rib fracture
3%
Drug withdrawal syndrome
3%
Alcohol poisoning
3%
Contusion
3%
Cerebral microangiopathy
3%
Dysarthria
3%
Memory impairment
3%
Movement disorder
3%
Monarthritis
3%
Neck pain
3%
Adverse drug reaction
3%
Cyst
3%
Implant site haematoma
3%
Oedema peripheral
3%
Pyrexia
3%
Pleural effusion
3%
Nerve root lesion
3%
Anxiety
3%
Cough
3%
Fibula fracture
3%
Thermal burn
3%
Sciatica
3%
Anger
3%
Bursitis
3%
Cystitis
3%
Helicobacter gastritis
3%
Implant site infection
3%
Localised infection
3%
Pneumonia
3%
Staphylococcal infection
3%
Confusional state
3%
Depressed mood
3%
Hallucination, auditory
3%
Impulse-control disorder
3%
Insomnia
3%
Panic attack
3%
Rapid eye movements sleep abnormal
3%
Bronchitis
3%
Ear infection
3%
Incision site infection
3%
Arthralgia
3%
Axillary pain
3%
Folate deficiency
3%
Hypertension
3%
Hypotension
3%
Thrombophlebitis
3%
Laboratory test abnormal
3%
Weight increased
3%
Pericardial effusion
3%
Seborrhoeic keratosis
3%
Urinary incontinence
100%
80%
60%
40%
20%
0%
Study treatment Arm
Deep Brain Stimulation

Trial Design

1Treatment groups
Experimental Treatment
Group I: Deep Brain StimulationExperimental Treatment1 Intervention
Voice outcomes and Magnetic resonance imaging will be compared pre- and post-DBS (Deep brain stimulation) in patients with laryngeal dystonia and adductor laryngeal dystonia. The evaluators will be masked for analyzing the voice outcomes pre-and post-DBS
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Deep Brain Stimulation
2011
Completed Phase 2
~700

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
980 Previous Clinical Trials
983,289 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,698 Previous Clinical Trials
7,492,487 Total Patients Enrolled
1 Trials studying Spasmodic Dysphonia
53 Patients Enrolled for Spasmodic Dysphonia
S. Elizabeth Zauber, MDPrincipal InvestigatorIndiana University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who is allowed to join in this medical experiment?

"Eligibility for this clinical trial requires adductor spastic dysphonia of dystonia and an age range between 18 to 70. This research study is striving to recruit 12 participants in total."

Answered by AI

Are individuals aged 55 or above able to partake in this research?

"This medical trial has an age criteria of 18 to 70 years old, and is thus open for enrolment by those that meet this requirement."

Answered by AI

Are there any unfilled positions for participants in this experiment?

"At present, clinicaltrials.gov reports that this trial is not recruiting patients, as the post dated 9th September 2022 has been last updated on 16th August 2022. Nevertheless, 48 other trials are currently in search of participants at this time."

Answered by AI

What are the primary aims of this medical experiment?

"The primary aim of this experiment, tested before and after surgery over a 6-month period, is to measure changes in acoustic voice recordings. Secondary metrics include fluctuations on Neuropsychological testing Trails B (mental flexibility), Trails A (psychomotor speed) and the Voice Handicap Index - an indicator ranging from 0 to 120 which determines patients' vocal handicap severity."

Answered by AI
~0 spots leftby May 2024